Stevens-Johnson syndrome

(redirected from Steven-Johnson syndrome)
Also found in: Medical.

Ste·vens-John·son syndrome

 (stē′vənz-jŏn′sən)
n.
A severe inflammatory eruption of the skin and mucous membranes, usually occurring after an infection, with malignancy, or as an allergic reaction to drugs or other substances.

[After Albert Mason Stevens (1884-1945) and Frank Chambliss Johnson (1894-1934), American pediatricians.]
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.
References in periodicals archive ?
ANTIEPILEPTIC DRUGS were found to be linked with almost ninefold increased odds for two adverse skin reactions, Steven-Johnson syndrome and toxic epidermal necrolysis, compared with non-AED medication classes in an analysis of data from the Food and Drug Administration Adverse Event Reporting System (FAERS).
Naldi et al., "Medication use and the risk of Steven-Johnson syndrome or toxic epidermal necrolysis," New England Journal of Medicine, vol.
A clinicoetiological study of steven-johnson syndrome and toxic epidermal necrolysis.
In the realm of more specialized aspects of pediatric dermatology, we have some excellent tips on minimizing pain and anxiety during pediatric dermatology procedures in young children, as well as an article on Steven-Johnson Syndrome and toxic epidermal necrolysis, conditions we have to keep an eye out for given the incredible morbidity and rare but distressing mortality they are associated with.
Steven-Johnson Syndrome (SJS) is characterized by an onset with fever and flu-like symptoms, followed by inflammation of the mouth mucosa and conjunctivitis.